InMode Ltd.
NASDAQ Global Select•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. Moshe Mizrahy
- Full Time Employees
- 599
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Tavor Building Yokne'am Israel 2069206
- IPO Date
- Aug 8, 2019
- CIK
- 0001742692
- Website
- inmodemd.com
- Similar Companies
- Business
- InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Company News
InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock?
InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade)
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
InMode to Present at the 24th Annual Needham Virtual Healthcare Conference
Is InMode (INMD) Stock Undervalued Right Now?
InMode Responds to Doma Perpetual's Letters
InMode to Present at Upcoming Investor Conferences
InMode: Plastic Surgery Boom, Cash Flow, And Cheap
InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript
InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
InMode: A Clear Bargain With Unique Risks
InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback
InMode: Clearly, I Was Too Optimistic (Rating Downgrade)
InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M
InMode: Product Origination And Undervaluation Make The Stock A Buy
InMode to Present at Upcoming Investor Conferences
InMode: $25/Share Is Closer Than You Think
InMode: A Deep Dive After Q3 Earnings